Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 44: 2433-2440, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (102)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katrukha, A. G.
Right arrow Articles by Gusev, N. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katrukha, A. G.
Right arrow Articles by Gusev, N. B.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 1998;44:2433-2440.)
© 1998 American Association for Clinical Chemistry, Inc.

Enzymes and Protein Markers

Degradation of cardiac troponin I: implication for reliable immunodetection

Aleksei G. Katrukha1,a, Anastasia V. Bereznikova2, Vladimir L. Filatov2, Tatiana V. Esakova3, Olga V. Kolosova3, Kim Pettersson4, Timo Lövgren4, Tamara V. Bulargina2, Igor R. Trifonov5, Nikolai A. Gratsiansky5, Kari Pulkki6, Liisa-Maria Voipio-Pulkki6 and Nikolai B. Gusev2

1 HyTest LTD, Tykistokatu 6A, FIN-20520 Turku, Finland.

2 Departments of Biochemistry and Bioorganic Chemistry, School of Biology, Moscow State University, 119899 Moscow, Russia.

3 Department of Biotechnology, Institute of Medical Ecology, Simpheropolskiy bull. 8, 113149 Moscow, Russia.

4 Department of Biotechnology, University of Turku, Tykistokatu 6A, FIN-20520 Turku, Finland.

5 Center for Atherosclerosis, 29th Moscow City Hospital, 119828 Moscow, Russia.

6 Turku University Hospital, Central Laboratory, Kiinanmyllynkaty 4–8, FIN-20520 Turku, Finland.
a Author for correspondence. Fax 358-2-3338070; e-mail hytest{at}utu.fi.

We have analyzed by different immunological methods the proteolytic degradation of cardiac troponin I (cTnI) in human necrotic tissue and in serum. cTnI is susceptible to proteolysis, and its degradation leads to the appearance of a wide diversity of proteolytic peptides with different stabilities. N- and C-terminal regions were rapidly cleaved by proteases, whereas the fragment located between residues 30 and 110 demonstrated substantially higher stability, possibly because of its protection by TnC. We conclude that antibodies selected for cTnI sandwich immunoassays should preferentially recognize epitopes located in the region resistant to proteolysis. Such an approach can be helpful for a much needed standardization of cTnI immunoassays and can improve the sensitivity and reproducibility of cTnI assays.




The following articles in journals at HighWire Press have cited this article:


Home page
 Ann. Thorac. Surg.Home page
L. Petaja, M. Salmenpera, K. Pulkki, and V. Pettila
Biochemical Injury Markers and Mortality After Coronary Artery Bypass Grafting: A Systematic Review.
Ann. Thorac. Surg., June 1, 2009; 87(6): 1981 - 1992.e3.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
K. Pettersson, S. Eriksson, S. Wittfooth, E. Engstrom, M. Nieminen, and J. Sinisalo
Autoantibodies to Cardiac Troponin Associate with Higher Initial Concentrations and Longer Release of Troponin I in Acute Coronary Syndrome Patients
Clin. Chem., May 1, 2009; 55(5): 938 - 945.
[Abstract] [Full Text] [PDF]

Home page
 Ann Clin BiochemHome page
D. C Gaze and P. O Collinson
Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance
Ann Clin Biochem, July 1, 2008; 45(4): 349 - 355.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. H. Christenson, S. H. Duh, F. S. Apple, G. S. Bodor, D. M. Bunk, M. Panteghini, M. J. Welch, A. H.B. Wu, S. E. Kahn, and for the American Association for Clinical Chemistr
Toward Standardization of Cardiac Troponin I Measurements Part II: Assessing Commutability of Candidate Reference Materials and Harmonization of Cardiac Troponin I Assays
Clin. Chem., September 1, 2006; 52(9): 1685 - 1692.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. N. Fahie-Wilson, D. J. Carmichael, M. P. Delaney, P. E. Stevens, E. M. Hall, and E. J. Lamb
Cardiac Troponin T Circulates in the Free, Intact Form in Patients with Kidney Failure
Clin. Chem., March 1, 2006; 52(3): 414 - 420.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Panteghini
Standardization of Cardiac Troponin I Measurements: The Way Forward?
Clin. Chem., September 1, 2005; 51(9): 1594 - 1597.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Eriksson, T. Ilva, C. Becker, J. Lund, P. Porela, K. Pulkki, L.-M. Voipio-Pulkki, and K. Pettersson
Comparison of Cardiac Troponin I Immunoassays Variably Affected by Circulating Autoantibodies
Clin. Chem., May 1, 2005; 51(5): 848 - 855.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Eriksson, H. Halenius, K. Pulkki, J. Hellman, and K. Pettersson
Negative Interference in Cardiac Troponin I Immunoassays by Circulating Troponin Autoantibodies
Clin. Chem., May 1, 2005; 51(5): 839 - 847.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
M. Kemp, J. Donovan, H. Higham, and J. Hooper
Biochemical markers of myocardial injury
Br. J. Anaesth., July 1, 2004; 93(1): 63 - 73.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
J. A. Simpson, J. Van Eyk, and S. Iscoe
Respiratory muscle injury, fatigue and serum skeletal troponin I in rat
J. Physiol., February 1, 2004; 554(3): 891 - 903.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. B. Marston and C. S. Redwood
Modulation of Thin Filament Activation by Breakdown or Isoform Switching of Thin Filament Proteins: Physiological and Pathological Implications
Circ. Res., December 12, 2003; 93(12): 1170 - 1178.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Eriksson, M. Junikka, P. Laitinen, K. Majamaa-Voltti, H. Alfthan, and K. Pettersson
Negative Interference in Cardiac Troponin I Immunoassays from a Frequently Occurring Serum and Plasma Component
Clin. Chem., July 1, 2003; 49(7): 1095 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. Labugger, J. A. Simpson, M. Quick, H. A. Brown, C. E. Collier, I. Neverova, and J. E. Van Eyk
Strategy for Analysis of Cardiac Troponins in Biological Samples with a Combination of Affinity Chromatography and Mass Spectrometry
Clin. Chem., June 1, 2003; 49(6): 873 - 879.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Lavoinne, B. Cauliez, H. Eltchaninoff, C. Tron, and A. Cribier
Release of Macromolecular Cardiac Troponin I Complex after Successful Percutaneous Transluminal Coronary Angioplasty in Acute Myocardial Infarction
Clin. Chem., March 1, 2003; 49(3): 505 - 507.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
A. van der Laarse
Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure
Cardiovasc Res, October 1, 2002; 56(1): 8 - 14.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. Uettwiller-Geiger, A. H.B. Wu, F. S. Apple, A. W. Jevans, P. Venge, M. D. Olson, C. Darte, D. L. Woodrum, S. Roberts, and S. Chan
Multicenter Evaluation of an Automated Assay for Troponin I
Clin. Chem., June 1, 2002; 48(6): 869 - 876.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. S. Jaffe
Testing the wrong hypothesis: the failure to recognize the limitations of troponin assays
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 999 - 1001.
[Full Text] [PDF]

Home page
 CirculationHome page
R. C. Payne, B. I. Bluestein, D. L. Morris, R. Labugger, L. Organ, C. Collier, J. E. Van Eyk, and D. Atar
Extensive Troponin I and T Modification Detected in Serum From Patients With Acute Myocardial Infarction Response
Circulation, July 31, 2001; 104 (5): e26 - e27.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. Venge, B. Lindahl, and L. Wallentin
New Generation Cardiac Troponin I Assay for the Access Immunoassay System
Clin. Chem., May 1, 2001; 47(5): 959 - 961.
[Full Text] [PDF]

Home page
 CirculationHome page
A. S. Jaffe, J. Ravkilde, R. Roberts, U. Naslund, F. S. Apple, M. Galvani, and H. Katus
It's Time for a Change to a Troponin Standard
Circulation, September 12, 2000; 102(11): 1216 - 1220.
[Full Text] [PDF]

Home page
 CirculationHome page
R. Labugger, L. Organ, C. Collier, D. Atar, and J. E. Van Eyk
Extensive Troponin I and T Modification Detected in Serum From Patients With Acute Myocardial Infarction
Circulation, September 12, 2000; 102(11): 1221 - 1226.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Altinier, M. Mion, A. Cappelletti, M. Zaninotto, and M. Plebani
Rapid Measurement of Cardiac Markers on Stratus CS
Clin. Chem., July 1, 2000; 46(7): 991 - 993.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. Ravkilde
Risk Stratification in Acute Coronary Syndrome Using Cardiac Troponin I
Clin. Chem., April 1, 2000; 46(4): 443 - 444.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. A. Morrow, N. Rifai, M. J. Tanasijevic, D. R. Wybenga, J. A. de Lemos, and E. M. Antman
Clinical Efficacy of Three Assays for Cardiac Troponin I for Risk Stratification in Acute Coronary Syndromes: A Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy
Clin. Chem., April 1, 2000; 46(4): 453 - 460.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. H. Wilson, D. M. Laird, C. M. Forsythe, T. T. Biegalski, A. L. Keller, and R. J. Herrmann
Antibody Selection for the Abbott AxSYM Troponin I Assay
Clin. Chem., December 1, 1999; 45(12): 2293 - 2294.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
Q. Shi, M. Ling, X. Zhang, M. Zhang, L. Kadijevic, S. Liu, and J. P. Laurino
Degradation of Cardiac Troponin I in Serum Complicates Comparisons of Cardiac Troponin I Assays
Clin. Chem., July 1, 1999; 45(7): 1018 - 1025.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. J. Newman, Y. Olabiran, W. D. Bedzyk, S. Chance, E. G. Gorman, and C. P. Price
Impact of Antibody Specificity and Calibration Material on the Measure of Agreement between Methods for Cardiac Troponin I
Clin. Chem., June 1, 1999; 45(6): 822 - 828.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
F. S. Apple
Clinical and Analytical Standardization Issues Confronting Cardiac Troponin I
Clin. Chem., January 1, 1999; 45(1): 18 - 20.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.